Squarepoint
ASMB icon

Squarepoint’s Assembly Biosciences ASMB Stock Holding History

Squarepoint’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$661K Buy
+23,804
New +$679K ﹤0.01% 3112
2025
Q2 		– Sell
-18,982
Closed -$181K – 4471
2025
Q1 		$181K Buy
+18,982
New +$248K ﹤0.01% 4048
2023
Q1 		– Sell
-874
Closed -$13.6K – 3211
2022
Q4 		$13.6K Buy
+874
New +$14.9K ﹤0.01% 3115
2022
Q1 		– Sell
-1,112
Closed -$31K – 2793
2021
Q4 		$31K Buy
+1,112
New +$36.5K ﹤0.01% 3069
2021
Q2 		– Sell
-2,883
Closed -$159K – 3208
2021
Q1 		$159K Sell
2,883
-806
-22% -$53.4K ﹤0.01% 2776
2020
Q4 		$268K Buy
3,689
+2,216
+150% +$260K ﹤0.01% 2293
2020
Q3 		$291K Buy
1,473
+395
+37% +$99.5K ﹤0.01% 1819
2020
Q2 		$302K Buy
+1,078
New +$252K ﹤0.01% 1600
2020
Q1 		– Sell
-3,577
Closed -$878K – 1849
2019
Q4 		$878K Sell
3,577
-1,328
-27% -$245K 0.01% 1416
2019
Q3 		$579K Buy
4,905
+3,480
+244% +$526K 0.01% 1535
2019
Q2 		$231K Buy
+1,425
New +$271K ﹤0.01% 2052
2019
Q1 		– Sell
-2,186
Closed -$593K – 2128
2018
Q4 		$593K Buy
2,186
+1,526
+231% +$441K 0.01% 1161
2018
Q3 		$294K Buy
660
+227
+52% +$106K ﹤0.01% 1549
2018
Q2 		$204K Buy
+433
New +$229K ﹤0.01% 1537
2018
Q1 		– Sell
-692
Closed -$376K – 1672
2017
Q4 		$376K Buy
+692
New +$313K 0.01% 1362

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Squarepoint's ASMB Position: Q1 2026 in Review

Squarepoint opened a new position in Assembly Biosciences (ASMB) in Q1 2026: 23,804 shares worth $661K. The stake represents ﹤0.01% of the portfolio and ranks #3112 among its holdings. This is a return to the name: Squarepoint previously reported a position in ASMB as recently as Q1 2025.

Squarepoint first reported a position in ASMB in Q4 2017 and has held it in 15 quarters since. The position peaked at $878K in Q4 2019. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • Squarepoint held 23,804 shares of Assembly Biosciences worth $661K as of Q1 2026.
  • Assembly Biosciences was a new Squarepoint position in Q1 2026.
  • Assembly Biosciences made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3112 holding.
  • Squarepoint first reported a position in Assembly Biosciences in Q4 2017 and has held it in 15 quarters since.
  • Squarepoint's Assembly Biosciences position peaked at $878K in Q4 2019.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.